2|0|Public
5000|$|Second {{generation}} drugs include glibenclamide (glyburide), glibornuride, gliclazide, glipizide, gliquidone, glisoxepide and <b>glyclopyramide.</b>|$|E
50|$|<b>Glyclopyramide</b> (INN, marketed {{under the}} tradename Deamelin-S) is a {{sulfonylurea}} drug {{used in the}} treatment of diabetes. It has been marketed in Japan since 1965.|$|E

